Auerbach BD, Rodrigues PV, Salvi RJ
2.2 Inclusion and exclusion criteria The inclusion criterion was original case reports describing kidney injury associated with semaglutide use

Raj Reddy, President and Chief Executive Officer, Canary Global, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, Saleha Patel, Head of Pipeline and Commercialisation Strategy, Constructive Bio, Lin Quek, Associate Director, Gene Therapy Research, Fractyl Health, Andrew Young, Chief Scientific and Medical Officer, I2O Therapeutics, Eduardo Martins, Chief Medical Officer, Sagimet Biosciences, Punit Dhillon, Chief Executive Officer and Director, Skye Biosciences, Steven Dickman, Founder and Chief Executive Officer, CBT Advisors, Marco Falasca, Professor, Metabolic Signalling, Department of Medicine and Surgery, Curtin University, Melissa Jones, Program Manager, Metabolic Disorders, FNIH, Niharika Samala, Associate Professor, Indiana University School of Medicine, Lawrence J Olson, Biotechnology Equity Research Analyst, Oppenheimer and Co., Krishna Kumar, Robinson Professor of Chemistry, Tufts University, Winston Dunn, Associate Professor, University of Kansas, Medical Center, Ashwani Singal, Professor of Medicine, University of Louisville Saturday, Aug 08, 2026 1:00p Club Volo at Assembly Row

At the Health and Vitality Center, a leading Functional Medicine Center in Los Angeles, Glutathione IV treatment is beneficial for: Chronic Fatigue Syndrome and Fibromyalgia Stroke, MS, Parkinsons disease Mold toxicity Cipro or Levaquin toxicity Elevated Liver Enzymes Detoxification Skin Lightening